These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10783065)

  • 1. Molecular dynamics simulations of bovine cathepsin B and its complex with CA074.
    Yamamoto A; Tomoo K; Miyagawa H; Takaoka Y; Sumiya S; Kitamura K; Ishida T
    Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):480-5. PubMed ID: 10783065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex.
    Yamamoto A; Tomoo K; Hara T; Murata M; Kitamura K; Ishida T
    J Biochem; 2000 Apr; 127(4):635-43. PubMed ID: 10739956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex.
    Yamamoto A; Hara T; Tomoo K; Ishida T; Fujii T; Hata Y; Murata M; Kitamura K
    J Biochem; 1997 May; 121(5):974-7. PubMed ID: 9192742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding mode of an E-64 analog to the active site of cathepsin B.
    Feng MH; Chan SL; Xiang Y; Huber CP; Lim C
    Protein Eng; 1996 Nov; 9(11):977-86. PubMed ID: 8961350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex.
    Yamamoto A; Tomoo K; Matsugi K; Hara T; In Y; Murata M; Kitamura K; Ishida T
    Biochim Biophys Acta; 2002 Jun; 1597(2):244-51. PubMed ID: 12044902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray crystal structure of papain complexed with cathepsin B-specific covalent-type inhibitor: substrate specificity and inhibitory activity.
    Matsumoto K; Murata M; Sumiya S; Mizoue K; Kitamura K; Ishida T
    Biochim Biophys Acta; 1998 Mar; 1383(1):93-100. PubMed ID: 9546050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.
    Krupa JC; Hasnain S; Nägler DK; Ménard R; Mort JS
    Biochem J; 2002 Feb; 361(Pt 3):613-9. PubMed ID: 11802791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
    Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
    Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary X-ray study of the cathepsin B complexed with CA074, a selective inhibitor.
    Yamamoto A; Kaji T; Tomoo K; Ishida T; Inoue M; Murata M; Kitamura K
    J Mol Biol; 1992 Oct; 227(3):942-4. PubMed ID: 1404397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.
    Musil D; Zucic D; Turk D; Engh RA; Mayr I; Huber R; Popovic T; Turk V; Towatari T; Katunuma N
    EMBO J; 1991 Sep; 10(9):2321-30. PubMed ID: 1868826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
    Therrien C; Lachance P; Sulea T; Purisima EO; Qi H; Ziomek E; Alvarez-Hernandez A; Roush WR; Ménard R
    Biochemistry; 2001 Mar; 40(9):2702-11. PubMed ID: 11258881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA074 methyl ester: a proinhibitor for intracellular cathepsin B.
    Buttle DJ; Murata M; Knight CG; Barrett AJ
    Arch Biochem Biophys; 1992 Dec; 299(2):377-80. PubMed ID: 1444478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by global cerebral ischemia/reperfusion injury in rats.
    Xu Y; Wang J; Song X; Wei R; He F; Peng G; Luo B
    Brain Res Bull; 2016 Jan; 120():97-105. PubMed ID: 26562519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.
    Turk D; Podobnik M; Popovic T; Katunuma N; Bode W; Huber R; Turk V
    Biochemistry; 1995 Apr; 34(14):4791-7. PubMed ID: 7718586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design.
    Jia Z; Hasnain S; Hirama T; Lee X; Mort JS; To R; Huber CP
    J Biol Chem; 1995 Mar; 270(10):5527-33. PubMed ID: 7890671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Features of CA-074 pH-Dependent Inhibition of Cathepsin B.
    Yoon MC; Christy MP; Phan VV; Gerwick WH; Hook G; O'Donoghue AJ; Hook V
    Biochemistry; 2022 Feb; 61(4):228-238. PubMed ID: 35119840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the occluding loop in cathepsin B activity.
    Illy C; Quraishi O; Wang J; Purisima E; Vernet T; Mort JS
    J Biol Chem; 1997 Jan; 272(2):1197-202. PubMed ID: 8995421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosomal proteolysis of insulin-like growth factor-I at its C-terminal D-domain by cathepsin B.
    Authier F; Kouach M; Briand G
    FEBS Lett; 2005 Aug; 579(20):4309-16. PubMed ID: 16051222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.
    Chan VJ; Selzer PM; McKerrow JH; Sakanari JA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.